Back

China Reverses Meta’s $2 Billion Manus Acquisition

According to The Wall Street Journal, Chinese authorities ordered Meta’s Manus acquisition to be unwound, with investors including Benchmark receiving returns and existing Chinese investors potentially helping reverse the deal.

Fact Check
The core claim is well supported by multiple sources gathered in this run. Odaily’s newsflash explicitly attributes the decision to the foreign investment security review office under the NDRC and says the acquisition was prohibited and the parties were ordered to revoke the transaction. China blocks foreign acquisition of Manus project and China’s NDRC prohibits foreign acquisition of Manus project independently confirm that the office under the NDRC prohibited the foreign acquisition of Manus and ordered the deal unwound or revoked. China blocks Meta's $2 billion takeover of AI startup Manus aligns with the Meta-specific framing and transaction value. The only meaningful limitation is that I did not retrieve the original NDRC notice directly, so confidence is medium rather than high.
Summary

China blocked Meta’s acquisition of Manus and ordered the transaction to be unwound, according to The Wall Street Journal. The report says the decision followed a ban by the foreign investment security review office linked to China’s National Development and Reform Commission. As the reversal proceeds, investors in Manus, including Benchmark, have received their money back, while Tencent, Sequoia China, and ZhenFund may cooperate in the unwind. The existing topic record lists the deal at $2 billion, though earlier reports cited $3 billion to $5 billion, leaving a discrepancy in the reported valuation.

Terms & Concepts
  • National Development and Reform Commission: China’s top state planning agency, which is linked to major economic oversight and foreign investment review processes.
  • Acquisition: A transaction in which one company or project is purchased by another, transferring ownership or control.
  • Cross-border transaction: A deal involving parties from different countries, often subject to additional regulatory review and approval requirements.